COLON CANCER (HIGH-RISK STAGE III: PT4N1 OR PT1 TO 4 N2)

Clinical trials for COLON CANCER (HIGH-RISK STAGE III: PT4N1 OR PT1 TO 4 N2) explained in plain language.

Never miss a new study

Get alerted when new COLON CANCER (HIGH-RISK STAGE III: PT4N1 OR PT1 TO 4 N2) trials appear

Sign up with your email to follow new studies for COLON CANCER (HIGH-RISK STAGE III: PT4N1 OR PT1 TO 4 N2), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Major cancer trial tests stronger chemo to stop colon Cancer's return

Disease control Completed

This large international study tested whether a more intensive three-drug chemotherapy combination (mFOLFIRINOX) works better than a standard two-drug combination (mFOLFOX) after surgery for high-risk stage III colon cancer. The goal was to see which treatment better prevents the…

Matched conditions: COLON CANCER (HIGH-RISK STAGE III: PT4N1 OR PT1 TO 4 N2)

Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

COLON CANCER (HIGH-RISK STAGE III: PT4N1 OR PT1 TO 4 N2)

Get alerted when new COLON CANCER (HIGH-RISK STAGE III: PT4N1 OR PT1 TO 4 N2) trials appear

Major cancer trial tests stronger chemo to stop colon Cancer's return